Lethal Dose of Allergex (Chlorpheniramine Maleate) Tablets
There is no established lethal dose for chlorpheniramine maleate in humans, but severe toxicity and death have been reported at blood concentrations as low as 0.2 mg/L in combination with other drugs, and rhabdomyolysis has occurred after ingestion of 400 mg (100 tablets of 4 mg each). 1, 2
Clinical Context and Toxicity Data
The available evidence on chlorpheniramine maleate toxicity comes primarily from case reports rather than systematic dose-response studies:
Documented Fatal Case
A fatal intoxication case reported a blood chlorpheniramine concentration of 0.2 mg/L in combination with other over-the-counter medications (guaifenesin and diphenhydramine), resulting in death from combined drug effects 2. This represents the clearest documentation of lethal blood levels, though it occurred in a polypharmacy context.
Non-Fatal Severe Toxicity
A 14-year-old patient who ingested 400 mg of chlorpheniramine maleate (100 tablets × 4 mg) developed:
- Severe rhabdomyolysis with myoglobin >1,200 ng/mL
- Creatine kinase peaking at 11,219 U/L
- Palpitations and tachycardia
- The patient survived with supportive care 1
This case demonstrates that 400 mg can cause life-threatening complications but is not uniformly fatal with appropriate medical intervention.
Mechanism of Toxicity
Chlorpheniramine overdose produces toxicity through multiple mechanisms:
- Anticholinergic effects: Central nervous system depression, hallucinations, confusion
- Cardiac effects: Tachycardia, arrhythmias, potential QT prolongation (though less pronounced than with some other antihistamines) 3
- Muscular toxicity: Rhabdomyolysis (rare but documented) 1
- Organ dysfunction: Potential renal and hepatic complications
Critical Clinical Pitfalls
The FDA drug label for Allergex warns to seek immediate medical help in case of overdose and contact Poison Control (1-800-222-1222) 4. This is the most authoritative guidance available.
Key Points for Clinical Management:
First-generation antihistamines like chlorpheniramine are particularly dangerous in overdose due to their anticholinergic properties and CNS effects 5
Elderly patients are at higher risk - first-generation antihistamines are considered potentially inappropriate medications in geriatric populations due to increased risk of confusion, falls, and anticholinergic toxicity 5
Combination with other sedatives or anticholinergic drugs dramatically increases risk - the fatal case involved multiple drugs, highlighting synergistic toxicity 2
Therapeutic doses are far below toxic levels: Standard dosing is 4-12 mg/day orally 3, 6, making the 400 mg ingestion represent a 33-100 fold overdose
Management Approach
In suspected chlorpheniramine overdose:
- Immediate gastrointestinal decontamination if presenting within appropriate timeframe
- Aggressive hydration and diuresis to prevent rhabdomyolysis complications 1
- Cardiac monitoring for arrhythmias and QT changes
- Electrolyte monitoring and correction
- Supportive care for CNS depression and anticholinergic syndrome
- Contact Poison Control immediately 4
The absence of a clearly defined LD50 in humans means any intentional overdose should be treated as potentially life-threatening, with aggressive supportive care and monitoring for at least 24 hours given the long elimination half-life (approximately 20 hours) 6.